SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-069939
Filing Date
2022-06-10
Accepted
2022-06-10 09:27:20
Documents
12
Period of Report
2022-06-09
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2218072d1_8k.htm   iXBRL 8-K 31202
  Complete submission text file 0001104659-22-069939.txt   204439

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA atxs-20220609.xsd EX-101.SCH 3036
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20220609_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20220609_pre.xml EX-101.PRE 22597
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2218072d1_8k_htm.xml XML 3612
Mailing Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110
Business Address 100 HIGH STREET 28TH FLOOR BOSTON MA 02110 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 221007787
SIC: 2834 Pharmaceutical Preparations